Zhang, Y., Yang, B., Zhao, J., Li, X., Zhang, L., & Zhai, Z. (2018). Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling. Med Sci Monit.
Citação norma ChicagoZhang, Yunjing, Bin Yang, Jinping Zhao, Xiaoli Li, Long Zhang, and Zhenhua Zhai. "Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel On Breast Cancer By Inhibiting Nuclear Factor (NF)-κB Signaling." Med Sci Monit 2018.
Citação norma MLAZhang, Yunjing, et al. "Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel On Breast Cancer By Inhibiting Nuclear Factor (NF)-κB Signaling." Med Sci Monit 2018.